Marcelo de Souza Fernandes Pereira

Dr. Marcelo de Souza Fernandes Pereira

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2022 in Cell Reports Methods
Verified
Journal Article
Open access
MKMeisam Naeimi Kararoudi
Meisam Naeimi Kararoudi
SLShibi Likhite
Shibi Likhite
EEEzgi Elmas
Ezgi Elmas
KYKenta Yamamoto
Kenta Yamamoto
MSMaura Schwartz
Maura Schwartz
DLDean Lee
Dean Lee
Human primary natural killer (NK) cells are being widely advanced for cancer immunotherapy. However, methods for gene editing of these cells have suffered low transduction rates, high cell death, and loss of transgene expression after expansion. Here, we developed a highly efficient method for site-specific gene insertion in NK cells using CRISPR (Cas9/RNP) and AAVs. We compared AAV vectors designed to mediate gene insertion by different DNA repair mechanisms, homology arm lengths, and virus concentrations. We then validated the method for site-directed gene insertion of CD33-specific CARs into primary human NK cells. CAR transduction was efficient, its expression remained stable after expansion, and it improved efficacy against AML targets.

25 July 2022 in The Cancer Journal
Verified
Journal Article
Open access
MPMarcelo de Souza Fernandes Pereira
Marcelo de Souza Fernandes Pereira
DCDavid R. Carr
David R. Carr
MGMargaret E. Gatti-Mays
Margaret E. Gatti-Mays
MOMallery R. Olsen
Mallery R. Olsen
BSBhuvana Setty
Bhuvana Setty
DLDean Lee
Dean Lee
Natural killer (NK) cells possess an innate ability to recognize cancer and are key mediators of cytotoxic efficacy for anticancer antibodies. Recent advances in the ability to generate, qualify, and safely infuse NK cells have led to a wide variety of clinical trials in oncology. Although their efficacy is best established for liquid cancers, their potential application in solid cancers has received increased attention. Here, we provide general background across a disparate group of exemplary solid tumors for which there is evidence for an NK cell role, discuss NK cell recognition motifs specific to each and murine and human studies of each that are supportive of NK cell adoptive immunotherapy, and end with special considerations relevant to the solid tumor microenvironment.

10 February 2022
Verified
Book Chapter
Closed access
MPMarcelo de Souza Fernandes Pereira
Marcelo de Souza Fernandes Pereira
ATAarohi Thakkar
Aarohi Thakkar
DLDean Anthony Lee
Dean Anthony Lee

24 January 2023 in Cancers
Verified
Journal Article
Open access
PDF file
MPMarcelo de Souza Fernandes Pereira
Marcelo de Souza Fernandes Pereira
KSKinnari Sorathia
Kinnari Sorathia
YSYasemin Sezgin
Yasemin Sezgin
ATAarohi Thakkar
Aarohi Thakkar
CMColin Maguire
Colin Maguire
MKMeisam Naeimi Kararoudi
Meisam Naeimi Kararoudi
Loss of cytotoxicity and defective metabolism are linked to glycogen synthase kinase 3 beta (GSK3β) overexpression in natural killer (NK) cells from patients with acute myeloid leukemia or from healthy donors after expansion ex vivo with IL-15. Drug inhibition of GSK3β in these NK cells improves their maturation and cytotoxic activity, but the mechanisms of GSK3β-mediated dysfunction have not been well studied. Here, we show that expansion of NK cells with feeder cells expressing membrane-bound IL-21 maintained normal GSK3β levels, allowing us to study GSK3β function using CRISPR gene editing. We deleted GSK3B and expanded paired-donor knockout and wild-type (WT) NK cells and then assessed transcriptional and functional alterations induced by loss of GSK3β. Surprisingly, our data showed that deletion of GSK3B did not alter cytotoxicity, cytokine production, or maturation (as determined by CD57 expression). However, GSK3B-KO cells demonstrated significant changes in expression of genes related to rRNA processing, cell proliferation, and metabolic function, suggesting possible metabolic reprogramming. Next, we found that key genes downregulated in GSK3B-KO NK cells were upregulated in GSK3β-overexpressing NK cells from AML patients, confirming this correlation in a clinical setting. Lastly, we measured cellular energetics and observed that GSK3B-KO NK cells exhibited 150% higher spare respiratory capacity, a marker of metabolic fitness. These findings suggest a role for GSK3β in regulating NK cell metabolism.

12 November 2025 in Molecular Therapy Oncology
Verified
Journal Article
Open access
RDRavi Dhital
Ravi Dhital
MPMarcelo de Souza Fernandes Pereira
Marcelo de Souza Fernandes Pereira

26 February 2025 in Molecular Therapy Oncology
Verified
Journal Article
Open access
DLDean A. Lee
Dean A. Lee
MPMarcelo de Souza Fernandes Pereira
Marcelo de Souza Fernandes Pereira